Join OPS for an insightful in-person event exploring the evolving landscape of depression treatment. Our expert speakers will cover the full spectrum of pharmacological approaches: Dr. Beata Godlewska will discuss the science behind SSRIs, their effectiveness, and limitations; Dr. Sara Costi will present the groundbreaking potential of ketamine as a rapid-acting antidepressant; and Dr. Matthew Wall will bring the conversation back to psychedelics, such as psilocybin, and where this lies as a future tool in mental health treatment.